国产91亚洲福利精品一区二区,国产综合成人久久大片91,国产成人精品久久综合,久久久91精品国产一区二区三区,91福利国产在线在线播放,91精品国产高清久久久久久91,91精品国产福利在线观看麻豆,国产免费一区二区三区在线观看

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當(dāng)前位置: 首頁 > ATCC代理 > ProPakA.6 [PPA.6, ProPak-A.6]
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號(hào)
  • 創(chuàng)e慧谷42號(hào)樓B幢401室
ProPakA.6 [PPA.6, ProPak-A.6]
ProPakA.6 [PPA.6, ProPak-A.6]
規(guī)格:
貨期:
編號(hào):B165520
品牌:Mingzhoubio

標(biāo)準(zhǔn)菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 ProPakA.6 [PPA.6, ProPak-A.6]
商品貨號(hào) B165520
Organism Homo sapiens, human
Tissue kidney
Product Format frozen
Culture Properties adherent
Biosafety Level 2  [Cells contain adenovirus and CMV viral sequences]

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease Leukemia
Age fetus
Applications
The ProPak packaging cell lines produce either murine leukemia virus (MLV) xenotropic particles (ProPak-X cells; ATCC CRL-12007) or amphotropic particles (ProPak-A cells; ATCC CRL-12006 and ATCC CRL-12479).
They were derived from the human embryonic kidney line, 293 (see ATCC CRL-1573).
They secrete defective (non-infectious) murine leukemia virus (MLV) particles composed of gag-pol and env proteins.
A vector that consistently gives rise to replication-competent retrovirus (RCR) in PA317 cells never results in detectable RCR in ProPak-A-based producer cultures.
ProPak-based producer cells were demonstrated to be free of replication-competent retrovirus (RCR) by stringent testing.
Consistently higher transduction of target cells was achieved with ProPak-derived amphotropic vector than with PA317-packaged amphotropic vector.
Storage Conditions liquid nitrogen vapor phase
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation
They were derived from the human embryonic kidney line, 293 (see ATCC CRL-1573).
Consistently higher transduction of target cells was achieved with ProPak-derived amphotropic vector than with PA317-packaged amphotropic vector.
Comments
The ProPak packaging cell lines produce either murine leukemia virus (MLV) xenotropic particles (ProPak-X cells; ATCC CRL-12007) or amphotropic particles (ProPak-A cells; ATCC CRL-12006 and ATCC CRL-12479).
They were derived from the human embryonic kidney line, 293 (see ATCC CRL-1573).
To derive the amphotropic packaging cell line ProPakA.6, the pCMVEa plasmid was introduced into 293 cells by co-transfection with the pHA58 plasmid conferring resistance to hygromycin B (250 mg/ml).
Clones were subsequently transfected with gag-pol and vector plasmids.
Next, the pCMV-gp construct was stably transfected into the 293-Env clones by cotransfection with the plasmid pSV2pac.
The cells are puromycin-resistant (1 mg/ml). They secrete defective (non-infectious) murine leukemia virus (MLV) particles composed of gag-pol and env proteins.
ProPak-A is a stable amphotropic packaging cell line in which the Gag-Pol and Env (packaging) functions are expressed separately from a heterologous (non-MLV) promoter, to maximally reduce homology between packaging and vector sequences
A vector that consistently gives rise to replication-competent retrovirus (RCR) in PA317 cells never results in detectable RCR in ProPak-A-based producer cultures.
ProPak-based producer cells were demonstrated to be free of replication-competent retrovirus (RCR) by stringent testing.
Consistently higher transduction of target cells was achieved with ProPak-derived amphotropic vector than with PA317-packaged amphotropic vector.
The highest transduction of human hematopoietic progenitor cells was achieved with vector supernatant generated from a coculture of the ProPak-X and ProPak-A cell lines.
Complete Growth Medium The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.
  3. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
  5. Add appropriate aliquots of the cell suspension to new culture vessels.
  6. Incubate cultures at 37°C.

Subcultivation Ratio: 1:4 to 1:10
Medium Renewal: Every 2 to 3 days

Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.

Cryopreservation

Complete growth medium described above supplemented with 5% (v/v) DMSO.  Cell culture tested DMSO is available as ATCC Catalog No. 4-X.

Culture Conditions
Temperature: 37°C
Atmosphere: Air, 95%; Carbon dioxide (CO2), 5%
Name of Depositor SyStemix, Inc.
Deposited As human
U.S. Patent Number
References

Rigg RJ, et al. Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant. US Patent 6,017,761 dated Jan 25 2000

Rigg RJ, et al. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology 218: 290-295, 1996. PubMed: 8615038

Forestell SP, et al. Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Ther. 4: 600-610, 1997. PubMed: 9231077

Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.

Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.

Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.

梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
绵阳市| 从江县| 宁晋县| 阆中市| 东阳市| 修水县| 当阳市| 龙游县| 梁平县| 颍上县| 遂昌县| 泰顺县| 东丰县| 普兰店市| 灵丘县| 潼南县| 荆门市| 连江县| 甘肃省| 东阳市| 阿勒泰市| 保靖县| 慈溪市| 凤城市| 深圳市| 金川县| 苍南县| 墨脱县| 固安县| 布尔津县| 长治市| 临海市| 封开县| 泰和县| 昭苏县| 新田县| 水城县| 龙门县| 姚安县| 西城区| 青浦区|